mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
4e-06 |
mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-05 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
1e-05 |
mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
0.45 |
1e-05 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
2e-05 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
4e-05 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-05 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-05 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
7e-05 |